




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Chronic Heart Failure</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=5e79e4a7-cd7b-4a2b-82bf-80c5e43672c5</link>
        <description>Clinical Topic Feed: Chronic Heart Failure</description>
        <language>en</language>

        

                <item>
                    <title>Kidney Function Decline May Precede HF Event by up to 1 Year in HFrEF Patients</title>
<link>/Latest-in-Cardiology/Journal-Scans/2025/08/05/10/10/Kidney-Function-Decline-May-Precede-HF-Event</link>                    <description>In patients with heart failure with reduced ejection fraction (HFrEF), kidney function decline may accelerate up to one year before a HF hospitalization or HF death, linking to symptomatic congestion, according to data from two clinical trials and a real-world study published July 30 in the European Heart Journal.</description>
                    <pubdate>1754415720000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>TAVR UNLOAD: Preemptive TAVR Not Superior to CASS in Patients With HFrEF and Moderate AS</title>
<link>/Latest-in-Cardiology/Articles/2024/10/24/19/43/mon-1144am-tavr-unload-tct-2024</link>                    <description>Findings from the TAVR UNLOAD trial found preemptive TAVR was not superior to clinical aortic stenosis surveillance (CASS) for the hierarchical occurrence of all-cause death, disabling stroke, disease-related hospitalizations and heart failure equivalents, and change in quality of life among patients with moderate aortic stenosis (AS) and heart failure with reduced ejection fraction (HFrEF) who are already receiving guideline-directed medical therapy (GDMT).</description>
                    <pubdate>1730130300000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Visual Abstract | TAVR UNLOAD</title>
<link>/education-and-meetings/image-and-slide-gallery/media-detail?id=7672921c032b4332968adbc7f3d5a7c4</link>                    <description></description>
                    <pubdate>1730088000000</pubdate>
                    <category>Images and Slides</category>
                </item>
                <item>
                    <title>Triage of Ambulatory Patients With Advanced HF</title>
<link>/Latest-in-Cardiology/Journal-Scans/2024/07/09/14/16/optimizing-triage-of-ambulatory</link>                    <description>What are 2-year clinical outcomes for ambulatory patients with advanced systolic heart failure (HF) on maximally tolerated evidence-based therapies?</description>
                    <pubdate>1720549800000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Novel Devices for Acute Cardiorenal Syndrome: Key Points</title>
<link>/Latest-in-Cardiology/ten-points-to-remember/2023/10/02/17/11/emerging-individualized-approaches</link>                    <description>The following are key points to remember from a state-of-the-art paper on novel devices for acute cardiorenal syndrome (CRS).</description>
                    <pubdate>1696271100000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: ESC Congress 2023 Follow-Up</title>
<link>/Latest-in-Cardiology/Articles/2023/09/01/00/46/eagles-eye-view-31aug2023</link>                    <description>In this special edition of the View, Dr. Eagle summarizes the top trials that were presented at the ESC Congress in Amsterdam from Friday, Aug. 25 through Monday, Aug. 28.</description>
                    <pubdate>1693529340000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View:&#226;€&#175;Day 1 &#226;€” ACCess Points Daily Wrap Up | ESC Congress 2023</title>
<link>/Latest-in-Cardiology/Articles/2023/08/18/12/35/eagles-eye-view-day1-highlights-esc-2023</link>                    <description>In this special edition of the View, Dr. Eagle talks with Dharam J. Kumbhani MD, SM, FACC, MACC, Philippe Gabriel Steg MD, and Payal Kohli MD about four of the major trials that were presented on Day 1 of the ESC Congress in Amsterdam on Friday, August 25.</description>
                    <pubdate>1692979200000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>STEP-HFpEF: Semaglutide Improves Symptoms, Physical Limitations, Weight Loss in Patients With HFpEF and Obesity</title>
<link>/Latest-in-Cardiology/Articles/2023/08/23/19/16/fri-515am-step-hfpef-esc-2023</link>                    <description>In patients with heart failure with preserved ejection fraction (HFpEF) and obesity, semaglutide improved heart failure-related symptoms and physical function, in addition to weight loss, based on findings from the STEP-HFpEF trial presented at ESC Congress 2023 and simultaneously published in the New England Journal of Medicine.</description>
                    <pubdate>1692954960000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACCEL Lite: Renal Considerations in the Management of Heart Failure</title>
<link>/Latest-in-Cardiology/Articles/2023/08/17/14/25/accel-lite-17aug2023</link>                    <description>In this interview, Paolo Colombo MD, FACC, and William E. Boden MD, FACC, FAHA, discuss Renal Considerations in the Management of Heart Failure.</description>
                    <pubdate>1692288000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: What is the potential of low-dose colchicine for secondary prevention of coronary artery disease?</title>
<link>/Latest-in-Cardiology/Articles/2023/08/09/16/33/eagles-eye-view-09aug2023</link>                    <description>In this week&#226;€™s View, Dr. Eagle explores the use of high-sensitivity cardiac troponin for risk assessment in patients with chronic coronary artery disease.</description>
                    <pubdate>1691598900000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>